PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis-9-Month Angiographic and 12-Month Clinical Results
Xu Bo,Gao Run-Lin,Wang Jian'an,et al.PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis-9-Month Angiographic and 12-Month Clinical Results[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2013,62(18):B18-B18.doi:10.1016/j.jacc.2013.08.788.
APA:
Xu, Bo,Gao, Run-Lin,Wang, Jian'an,Yang, Yuejin,Chen, Shao Liang...&Ge, Junbo.(2013).PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis-9-Month Angiographic and 12-Month Clinical Results.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,62,(18)
MLA:
Xu, Bo,et al."PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis-9-Month Angiographic and 12-Month Clinical Results".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 62..18(2013):B18-B18